Dendritic cell function in lupus: Independent contributors or victims of aberrant immune regulation

References

• Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002; 2:151–161.
   PubMed Web of Science ®Google Scholar
• Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J. CD34+hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 1996; 184:695–706.
   PubMed Web of Science ®Google Scholar
• Brigl M, Brenner MB. CD1: Antigen presentation and T-cell function. Annu Rev Immunol. 2004; 22:817–890.
   PubMed Web of Science ®Google Scholar
• Manolova V, Kistowska M, Paoletti S, Baltariu GM, Bausinger H, Hanau D, Mori L, De Libero G. Functional CD1a is stabilized by exogenous lipids. Eur J Immunol. 2006; 36:1083–1092.
   PubMed Web of Science ®Google Scholar
• Salamero J, Bausinger H, Mommaas AM, Lipsker D, Proamer F, Cazenave JP, Goud B, de la Salle H, Hanau D. CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. J Invest Dermatol. 2001; 116:401–408.
   PubMed Web of Science ®Google Scholar
• Moody DB, Porcelli SA. Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol. 2003; 3:11–22.
   PubMedGoogle Scholar
• Vincent MS, Gumperz JE, Brenner MB. Understanding the function of CD1-restricted T-cells. Nat Immunol. 2003; 4:517–523.
   PubMed Web of Science ®Google Scholar
• Caux C, Massacrier C, Vanbervliet B, Dubois B, Durand I, Cella M, Lanzavecchia A, Banchereau J. CD34+hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood. 1997; 90:1458–1470.
   Google Scholar
• Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18:767–811.
   PubMed Web of Science ®Google Scholar
• Gogolak P, Rethi B, Szatmari I, Lanyi A, Dezso B, Nagy L, Rajnavolgyi E. Differentiation of CD1a-and CD1a+monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood. 2007; 109:643–652.
   PubMedGoogle Scholar
• Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity. 1999; 11:753–761.
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005; 5:953–964.
   PubMed Web of Science ®Google Scholar
• Coutant F, Agaugue S, Perrin-Cocon L, Andre P, Lotteau V. Sensing environmental lipids by dendritic cell modulates its function. J Immunol. 2004; 172:54–60.
   Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994; 179:1109–1118.
   PubMed Web of Science ®Google Scholar
• Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Meth. 1999; 223:1–15.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392:245–252.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hemmi H. Dendritic cells: Translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006; 311:17–58.
   PubMed Web of Science ®Google Scholar
• Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol. 2005; 25:551–572.
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines. Cell. 2001; 106:255–258.
   PubMed Web of Science ®Google Scholar
• Kadowaki N. The divergence and interplay between pDC and mDC in humans. Front Biosci. 2009; 14:808–817.
   Google Scholar
• Tsokos GC. Overview of cellular immune function in systemic lupus erythematosus. In: Lahita RG. editors. Systemic Lupus Erythematosus . 2nd ed. New York: Churchill Livingstone, Inc.. 1992. 13–48.
   Google Scholar
• Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 2004; 20:539–550.
   PubMed Web of Science ®Google Scholar
• Marshall E. Lupus: Mysterious disease holds its secrets tight. Science. 2002; 296:689–691.
   PubMedGoogle Scholar
• Ishikawa S, Sato T, Abe M, Nagai S, Onai N, Yoneyama H, Zhang Y, Suzuki T, Hashimoto S, Shirai T, Lipp M, Matsushima K. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med. 2001; 193:1393–1402.
   PubMedGoogle Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003; 21:685–711.
   PubMed Web of Science ®Google Scholar
• Crispin JC, Alcocer-Varela J. The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus. Autoimmun Rev. 2007; 6:450–456.
   PubMed Web of Science ®Google Scholar
• Scheinecker C, Zwolfer B, Koller M, Manner G, Smolen JS. Alterations of dendritic cells in systemic lupus erythematosus: Phenotypic and functional deficiencies. Arthritis Rheum. 2001; 44:856–865.
   PubMedGoogle Scholar
• Koller M, Zwolfer B, Steiner G, Smolen JS, Scheinecker C. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int Immunol. 2004; 16:1595–1604.
   PubMedGoogle Scholar
• Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol. 2006; 177:5878–5889.
   PubMed Web of Science ®Google Scholar
• Decker P. Nucleosome autoantibodies. Clin Chim Acta. 2006; 366:48–60.
   PubMed Web of Science ®Google Scholar
• Decker P, Kotter I, Klein R, Berner B, Rammensee HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006; 45:1087–1095.
   PubMed Web of Science ®Google Scholar
• Fiore N, Castellano G, Blasi A, Capobianco C, Loverre A, Montinaro V, Netti S, Torres D, Manno C, Grandaliano G, Ranieri E, Schena FP, Gesualdo L. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol Immunol. 2008; 45:259–265.
   PubMed Web of Science ®Google Scholar
• Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001; 294:1540–1543.
   PubMed Web of Science ®Google Scholar
• Kato K, Santana-Sahagun E, Rassenti LZ, Weisman MH, Tamura N, Kobayashi S, Hashimoto H, Kipps TJ. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest. 1999; 104:947–955.
   PubMed Web of Science ®Google Scholar
• Decker P, Singh-Jasuja H, Haager S, Kotter I, Rammensee HG. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: Consequences on inflammation. J Immunol. 2005; 174:3326–3334.
   PubMed Web of Science ®Google Scholar
• Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol. 1999; 115:196–202.
   PubMed Web of Science ®Google Scholar
• Vallin H, Perers A, Alm GV, Ronnblom L, Anti-double-stranded DNA. antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol. 1999; 163:6306–6313.
   PubMed Web of Science ®Google Scholar
• Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005; 115:407–417.
   PubMed Web of Science ®Google Scholar
• Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F. Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis. 2000; 59:283–288.
   PubMed Web of Science ®Google Scholar
• Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8+T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2005; 52:201–211.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur J Immunol. 2008; 38:2896–2904.
   PubMed Web of Science ®Google Scholar
• Mevorach D. The role of death-associated molecular patterns in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am. 2004; 30:487–504 viii.
   PubMedGoogle Scholar
• Powell JD, Lerner CG, Ewoldt GR, Schwartz RH. The -180 site of the IL-2 promoter is the target of CREB/CREM binding in T-cell anergy. J Immunol. 1999; 163:6631–6639.
   PubMedGoogle Scholar
• Tenbrock K, Juang YT, Tolnay M, Tsokos GC. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T-cells by a chromatin-dependent mechanism. J Immunol. 2003; 170:2971–2976.
   PubMed Web of Science ®Google Scholar
• Ahlmann M, Varga G, Sturm K, Lippe R, Benedyk K, Viemann D, Scholzen T, Ehrchen J, Muller FU, Seidl M, Matus M, Tsokos GC, Roth J, Tenbrock K. The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function. J Immunol. 2009; 182:4167–4174.
   Google Scholar
• Laborde EA, Vanzulli S, Beigier-Bompadre M, Isturiz MA, Ruggiero RA, Fourcade MG. Catalan Pellet AC. Sozzani S, Vulcano M. Immune complexes inhibit differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2007; 179:673–681.
   Google Scholar
• Qi H, Li FR, Liu DZ, Xiao XL, Ren LL, Wen JL, Huang RF. [Study on the surface markers on peripheral blood dendritic cells and their secretion of IL-12 and IFN-alpha in SLE patients]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005; 21:499–501.
   Google Scholar
• Hughes GC, Clark EA. Regulation of dendritic cells by female sex steroids: Relevance to immunity and autoimmunity. Autoimmunity. 2007; 40:470–481.
   PubMed Web of Science ®Google Scholar
• Jara LJ, Benitez G, Medina G. Prolactin, dendritic cells, and systemic lupus erythematosus. Autoimmun Rev. 2008; 7:251–255.
   PubMed Web of Science ®Google Scholar
• Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2008; 15:243–250.
   PubMed Web of Science ®Google Scholar
• Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997; 390:350–351.
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K, Nussenzweig M. Dendritic cell function in vivo during the steady state: A role in peripheral tolerance. Ann N Y Acad Sci. 2003; 987:15–25.
   PubMed Web of Science ®Google Scholar
• Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol. 2002; 168:1627–1635.
   PubMed Web of Science ®Google Scholar
• Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000; 191:423–434.
   PubMed Web of Science ®Google Scholar
• Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol. 2004; 112:210–218.
   PubMed Web of Science ®Google Scholar
• Sheriff A, Gaipl US, Voll RE, Kalden JR, Herrmann M. Apoptosis and systemic lupus erythematosus. Rheum Dis Clin North Am. 2004; 30:505-527 viii–ix.
   Google Scholar
• Datta SK. Major peptide autoepitopes for nucleosome-centered T- and B- cell interaction in human and murine lupus. Ann N Y Acad Sci. 2003; 987:79–90.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1241–1250.
   PubMed Web of Science ®Google Scholar
• Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O, Kutikov I, Gill O, Mevorach D. Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med. 2002; 196:1553–1561.
   PubMed Web of Science ®Google Scholar
• Krispin A, Bledi Y, Atallah M, Trahtemberg U, Verbovetski I, Nahari E, Zelig O, Linial M, Mevorach D. Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood. 2006; 108:3580–3589.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Agresti A. HMG proteins: Dynamic players in gene regulation and differentiation. Curr Opin Genet Dev. 2005; 15:496–506.
   PubMed Web of Science ®Google Scholar
• Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000; 192:565–570.
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004; 279:7370–7377.
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN. Sama ATracey. KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999; 285:248–251.
   Google Scholar
• Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007; 8:487–496.
   PubMed Web of Science ®Google Scholar
• Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, Bianchi ME, Wang H, Chu WM. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood. 2007; 110:1970–1981.
   PubMed Web of Science ®Google Scholar
• Messmer D, Yang H, Telusma G, Knoll F, Li J, Messmer B, Tracey KJ, Chiorazzi N. High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol. 2004; 173:307–313.
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Muller S, Iannacone M, Traversari C, Bianchi ME, Manfredi AA. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004; 5:825–830.
   PubMed Web of Science ®Google Scholar
• Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 46:191–201.
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V, Furnrohr BG, Weber C, Haslbeck M, Wilhelm S, Herrmann M, Voll RE. Factors masking HMGB1 in human serum and plasma. J Leukoc Biol. 2007; 81:67–74.
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 2008; 205:3007–3018.
   PubMed Web of Science ®Google Scholar
• Walport MJComplement. First of two parts. N Engl J Med. 2001; 344:1058–1066.
   PubMed Web of Science ®Google Scholar
• Rovere P, Vallinoto C, Bondanza A, Crosti MC, Rescigno M, Ricciardi-Castagnoli P. Rugarli CManfredi AA. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J Immunol. 1998; 161:4467–4471.
   Google Scholar
• Wang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM. Straus SELenardo. MJ. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 1999; 98:47–58.
   Google Scholar
• Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, Meyer PA, Walport MJ. Hereditary C1q deficiency and systemic lupus erythematosus. Qjm. 1994; 87:455–464.
   Google Scholar
• Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun. 2001; 2:442–450.
   PubMed Web of Science ®Google Scholar
• Rovere P, Sabbadini MG, Vallinoto C, Fascio U, Recigno M, Crosti M, Ricciardi-Castagnoli P, Balestrieri G, Tincani AM, anfredi AA. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: Role of opsonizing anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 1999; 42:1412–1420.
   PubMed Web of Science ®Google Scholar
• Frisoni L, McPhie L, Colonna L, Sriram U, Monestier M, Gallucci S, Caricchio R. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: A novel pathogenic pathway for autoimmunity?. J Immunol. 2005; 175:2692–2701.
   PubMed Web of Science ®Google Scholar
• Plotz PH. The autoantibody repertoire: Searching for order. Nat Rev Immunol. 2003; 3:73–78.
   PubMed Web of Science ®Google Scholar
• Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D. Marshak-Rothstein AWeigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med. 1990; 171:265–292.
   Google Scholar
• Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002; 416:603–607.
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003; 21:335–376.
   PubMed Web of Science ®Google Scholar
• Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA. Bazan FLiu. YJ. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001; 194:863–869.
   Google Scholar
• Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004; 5:190–198.
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006; 440:808–812.
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004; 5:987–995.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M. Perez de Lema G. Strutz F, Bauer S, Rutz M, Wagner H, Grone HJ, Schlondorff D. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. Faseb J. 2004; 18:534–536.
   Google Scholar
• Patole PS, Grone HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlondorff D, Anders HJ. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol. 2005; 16:1326–1338.
   PubMed Web of Science ®Google Scholar
• Rahman AH, Eisenberg RA. The role of toll-like receptors in systemic lupus erythematosus. Springer Semin Immunopathol. 2006; 28:131–143.
   PubMed Web of Science ®Google Scholar
• Krystosek A. Preferential sites of early DNA cleavage in apoptosis and the pathway of nuclear damage. Histochem Cell Biol. 1999; 111:265–276.
   Google Scholar
• Sano H, Morimoto C. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J Immunol. 1982; 128:1341–1345.
   PubMed Web of Science ®Google Scholar
• Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005; 202:1131–1139.
   PubMed Web of Science ®Google Scholar
• Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004; 279:12542–12550.
   PubMed Web of Science ®Google Scholar
• Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med. 2004; 199:1631–1640.
   PubMed Web of Science ®Google Scholar
• Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, Wagner H, Schmid RM, Bauer S, Krug A. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood. 2006; 107:3229–3234.
   PubMed Web of Science ®Google Scholar
• Takaoka A, Taniguchi T, Cytosolic DNA. recognition for triggering innate immune responses. Adv Drug Deliv Rev. 2008; 60:847–857.
   Google Scholar
• Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T, The RNA, helicase RIG-I. has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004; 5:730–737.
   PubMed Web of Science ®Google Scholar
• Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS. Reis e Sousa C. Matsuura Y, Fujita T, Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006; 441:101–105.
   Google Scholar
• Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature. 2008; 452:103–107.
   PubMed Web of Science ®Google Scholar
• Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006; 24:93–103.
   PubMed Web of Science ®Google Scholar
• Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol. 2006; 7:40–48.
   PubMed Web of Science ®Google Scholar
• Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007; 448:501–505.
   PubMed Web of Science ®Google Scholar
• Schroder K, Muruve DA, Tschopp J. Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol. 2009; 19:R262–R265.
   PubMed Web of Science ®Google Scholar
• Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science. 2009; 323:1057–1060.
   PubMed Web of Science ®Google Scholar
• Choubey D, Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett. 2008; 119:32–41.
   PubMed Web of Science ®Google Scholar
• Mondini M, Vidali M, Airo P, De Andrea M, Riboldi P, Meroni PL, Gariglio M, Landolfo S. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann N Y Acad Sci. 2007; 1110:47–56.
   PubMedGoogle Scholar
• Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998; 19:56–59.
   PubMed Web of Science ®Google Scholar
• Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med. 1998; 188:2313–2320.
   PubMed Web of Science ®Google Scholar
• Tenner AJ, Volkin DB. Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. Biochem J. 1986; 233:451–458.
   PubMed Web of Science ®Google Scholar
• Vegh Z, Goyarts EC, Rozengarten K, Mazumder A, Ghebrehiwet B. Maturation-dependent expression of C1q-binding proteins on the cell surface of human monocyte-derived dendritic cells. Int Immunopharmacol. 2003; 3:345–357.
   Google Scholar
• Reis ES, Barbuto JA, Isaac L. Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. Immunobiology. 2007; 212:151–157.
   Google Scholar
• Cao W, Bobryshev YV, Lord RS, Oakley RE, Lee SH, Lu J. Dendritic cells in the arterial wall express C1q: Potential significance in atherogenesis. Cardiovasc Res. 2003; 60:175–186.
   Web of Science ®Google Scholar
• Castellano G, Woltman AM, Nauta AJ, Roos A, Trouw LA, Seelen MA, Schena FP, Daha MR, van Kooten C. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood. 2004; 103:3813–3820.
   Google Scholar
• Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004; 22:431–456.
   PubMed Web of Science ®Google Scholar
• Walport MJComplement. Second of two parts. N Engl J Med. 2001; 344:1140–1144.
   PubMed Web of Science ®Google Scholar
• Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol. 2004; 4:825–831.
   PubMed Web of Science ®Google Scholar
• Castellano G, Woltman AM, Schlagwein N, Xu W, Schena FP, Daha MR, van Kooten C. Immune modulation of human dendritic cells by complement. Eur J Immunol. 2007; 37:2803–2811.
   Google Scholar
• Csomor E, Bajtay Z, Sandor N, Kristof K, Arlaud GJ, Thiel S, Erdei A. Complement protein C1q induces maturation of human dendritic cells. Mol Immunol. 2007; 44:3389–3397.
   PubMed Web of Science ®Google Scholar
• Reis ES, Barbuto JA, Kohl J, Isaac L. Impaired dendritic cell differentiation and maturation in the absence of C3. Mol Immunol. 2008; 45:1952–1962.
   Google Scholar
• Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006; 54:2951–2962.
   PubMed Web of Science ®Google Scholar
• Liu YJ. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 2005; 23:275–306.
   PubMed Web of Science ®Google Scholar
• Gill MA, Blanco P, Arce E, Pascual V, Banchereau J, Palucka AK. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum Immunol. 2002; 63:1172–1180.
   PubMed Web of Science ®Google Scholar
• Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001; 159:237–243.
   PubMed Web of Science ®Google Scholar
• Lande R, Giacomini E, Serafini B, Rosicarelli B, Sebastiani GD, Minisola G, Tarantino U, Riccieri V, Valesini G, Coccia EM. Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol. 2004; 173:2815–2824.
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity. J Exp Med. 1999; 190:815–826.
   PubMed Web of Science ®Google Scholar
• Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: All roads lead to type I interferons. Curr Opin Immunol. 2006; 18:676–682.
   PubMed Web of Science ®Google Scholar
• Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 2004; 303:1662–1665.
   PubMed Web of Science ®Google Scholar
• Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science. 2006; 312:1672–1676.
   PubMed Web of Science ®Google Scholar
• Wykes M, Pombo A, Jenkins C, MacPherson GG. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J Immunol. 1998; 161:1313–1319.
   PubMed Web of Science ®Google Scholar
• Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res. 2004; 24:131–139.
   Google Scholar
• Gottenberg JE, Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie. 2007; 89:856–871.
   Google Scholar
• Richez C, Yasuda K, Watkins AA, Akira S, Lafyatis R, van Seventer JM, Rifkin IR. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J Immunol. 2009; 182:820–828.
   Google Scholar
• Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T-cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997; 185:1101–1111.
   PubMed Web of Science ®Google Scholar
• Liu K, Mohan C. What do mouse models teach us about human SLE?. Clin Immunol. 2006; 119:123–130.
   PubMed Web of Science ®Google Scholar
• Georgiev M, Agle LM, Chu JL, Elkon KB, Ashany D. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum. 2005; 52:225–238.
   PubMed Web of Science ®Google Scholar
• Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv Immunol. 2006; 92:1–69.
   PubMed Web of Science ®Google Scholar
• Zhu J, Liu X, Xie C, Yan M, Yu Y, Sobel ES, Wakeland EK, Mohan C. T-cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest. 2005; 115:1869–1878.
   PubMed Web of Science ®Google Scholar
• Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol. 2001; 167:2370–2378.
   Google Scholar
• Ishikawa S, Nagai S, Sato T, Akadegawa K, Yoneyama H, Zhang YY, Onai N, Matsushima K. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC. Eur J Immunol. 2002; 32:1881–1887.
   Google Scholar
• Adachi Y, Taketani S, Toki J, Ikebukuro K, Sugiura K, Oyaizu H, Yasumizu R, Tomita M, Kaneda H, Amoh Y, Ito T, Okigaki M, Inaba M, Ikehara S. Marked increase in number of dendritic cells in autoimmune-prone (NZW x BXSB)F1 mice with age. Stem Cells. 2002; 20:61–72.
   PubMed Web of Science ®Google Scholar
• Kalled SL, Cutler AH, Burkly LC. Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J Immunol. 2001; 167:1740–1747.
   PubMed Web of Science ®Google Scholar
• Wan S. Xia CMorel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+T-cell regulatory functions. J Immunol. 2007; 178:271–279.
   Google Scholar
• Funauchi M, Yoo BS, Nozaki Y, Sugiyama M, Ohno M, Kinoshita K, Kanamaru A. Dysregulation of the granulocyte-macrophage colony-stimulating factor receptor is one of the causes of defective expression of CD80 antigen in systemic lupus erythematosus. Lupus. 2002; 11:317–321.
   Google Scholar
• Ma L, Chan KW, Trendell-Smith NJ, Wu A, Tian L, Lam AC, Chan AK, Lo CK, Chik S, Ko KH, To CK, Kam SK, Li XS, Yang CH, Leung SY, Ng MH, Stott DI, MacPherson GG, Huang FP. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur J Immunol. 2005; 35:3364–3375.
   PubMedGoogle Scholar
• Bondanza A, Zimmermann VS, Dell'Antonio G. Dal Cin E. Capobianco A, Sabbadini MG, Manfredi AA, Rovere-Querini P. Cutting edge: Dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol. 2003; 170:24–27.
   Google Scholar
• Chen M, Wang YH, Wang Y, Huang L, Sandoval H, Liu YJ, Wang J. Dendritic cell apoptosis in the maintenance of immune tolerance. Science. 2006; 311:1160–1164.
   PubMed Web of Science ®Google Scholar
• Okamoto A, Fujio K, van Rooijen N, Tsuno NH, Takahashi K, Tsurui H, Hirose S, Elkon KB, Yamamoto K. Splenic phagocytes promote responses to nucleosomes in (NZB x NZW) F1 mice. J Immunol. 2008; 181:5264–5271.
   Google Scholar
• Colonna L, Dinnall JA, Shivers DK, Frisoni L, Caricchio R, Gallucci S. Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res Ther. 2006; 8:R49.
   PubMed Web of Science ®Google Scholar